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hat Should Be the Principle Imaging
est in Heart Failure—CMR or
chocardiography?
ichard E. Slaughter, MBBS, Philip M. Mottram, MBBS, PHD
risbane and Clayton, Australia
ection Editor: Thomas H. Marwick, MBBS, PHD
EART FAILURE (HF) REMAINS ONE OF THE MOST COMMON CAUSES OF HOSPITALIZATION and
eath in developed countries, with prevalence rates predicted to increase in line with population
ging. Imaging has an important role in patients with HF. It can quantify and monitor ventricular
erformance, establish a diagnosis, stratify risk, and evaluate many of the complications. However,
lthough intense research over recent decades has resulted in the development of many effective
reatments, accurate diagnosis of the condition remains difficult, despite significant advancement in
ardiac imaging technologies that are capable of evaluating myocardial structure, function, anderfusion.
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hilip M. Mottram, MBBS, PhD
onash Medical Centre, Clayton, Australia
F IS A CLINICAL SYNDROME THAT RE-
UIRES COMPREHENSIVE CLINICAL AS-
ESSMENT TO MAKE THE DIAGNOSIS. As
tated in the American College of Cardiol-
gy/American Heart Association guidelines,
here is no single diagnostic test for HF, and
ny single symptom or examination finding
as relatively low specificity in isolation (1).
iven the prevalence of HF and its associ-
tion with the elderly (who often have mo-
ility problems), the wide availability, rela-
ively low cost, and portability of Doppler
chocardiography are key advantages. It is
lso “patient friendly” and does not usually
equire intravenous cannulation, which enables txamination at the bedside in unstable
atients.
eft ventricular (LV) ﬁlling pressure. To deter-
ine which cardiac investigation is most useful
or the evaluation of patients with possible HF,
ne needs to consider the pathophysiology of
he most common clinical manifestation of the
yndrome, namely, exertional dyspnea. What-
ver the cause of dyspnea in a given patient,
hether it is due to LV systolic dysfunction,
iastolic dysfunction, or valvular disease, dys-
nea and exercise intolerance are associated
ith periodic or persistent elevation of left
trial and pulmonary venous pressures. Fortu-
ately, for a decade or more, Doppler echocar-
iography has been able to perform this func-
ion with high feasibility and reproducibility
nd an accuracy that has allowed the establish-
ent of clinically useful cutoffs for prediction
f elevated mean left atrial pressure in patients
ith suspected HF. The most validated tech-
ique uses pulsed-wave Doppler to relate the
eak velocity of early diastolic transmitral flow
o the peak velocity of early diastolic longitu-
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777inal motion at the mitral annulus, the
o-called E/e= ratio (2). When the ratio
s significantly elevated (for example
/e=15 using the lateral annulus) and
onfounders such as mitral valve disease
r rhythm disturbance are absent, the
linician can be quite confident that
ean left atrial pressure was elevated at
he time of the echocardiographic
tudy. In more borderline cases, inter-
retation can be aided by assessing the
ffect of load-altering maneuvers on the
ransmitral flow pattern as well as
ulsed-wave Doppler evaluation of pul-
onary venous flow (3). The E/e= ratio
an also be determined in serial echo-
ardiographic studies to guide pharma-
ological intervention and monitor re-
ponse to therapy in HF patients. In
ddition, the E/e= ratio is a strong
rognostic marker and independently
redicts adverse cardiac outcomes in
he HF population (4).
ulmonary artery pressure. In addition
o estimation of left atrial pressure,
oppler echocardiography has an im-
ortant application in the estimation of
eak systolic pulmonary artery pressure.
his is clinically relevant because pa-
ients with HF and elevated pulmonary
enous pressures often have accompa-
ying elevation of pulmonary artery
ystolic pressure. This is particularly
pplicable to hospitalized patients with
ecompensated HF in whom the de-
ree of pulmonary hypertension helps
nform the severity of HF and pro-
ides a marker for assessment of re-
ponse to treatment. The technique
ses continuous-wave Doppler interro-
ation of the tricuspid regurgitant sig-
al (recordable in at least 75% of pa-
ients) to determine the instantaneous
eak systolic pressure gradient between
he right ventricle and the right atrium
sing the modified Bernoulli equation
5). By adding an estimation of right
trial pressure, the right ventricular
eak systolic pressure can be obtained,
hich equates to pulmonary arterial
ystolic pressure in the absence of right
entricular outflow obstruction.jection fraction (EF) and LV volumes.
he identification of patients with sys-
olic dysfunction is a determinant of
ppropriate therapy, and it is likely for
his reason that the performance of
chocardiography is associated with
mproved outcome in heart failure (6).
ikewise, the measurement of LV vol-
mes is an independent and incremen-
al predictor of outcome. The problem
s that echocardiographic measurement
f both EF and volumes is sometimes
naccurate and often of unacceptable
ariability (7). Two new technologies
ave been shown to improve these lim-
tations in multicenter studies: LV
pacification (8) and 3-dimensional
3D) echocardiography (Fig. 1) (9).
Although there is no doubt as to the
owerful prognostic significance of LV
jection fraction (EF), its relationship
o the clinical syndrome of HF is often
isunderstood. For example, one pa-
ient with a dilated LV and poor EF of
5% may be severely symptomatic,
hereas another patient with similar
V function who is aggressively treated
ith neurohormonal blockade and di-
retics may be completely asymptom-
tic. The difference between these 2
Figure 1. Accurate Measurement of LV Volumes
The ability to trace the left ventricular (LV) border i
against short-axis images [bottom row, center]) pr
even in irregularly shaped ventricles.atients largely relates to differences in
ntravascular volume status and cardiac
lling pressures and highlights the clear
isconnect between LVEF and clinical
ymptoms in a given patient. In HF
ith reduced EF, information from the
ransmitral flow pattern and E/e= ratio
an, therefore, be applied clinically to
uide diuretic therapy as well as to
nform prognosis (10).
F with normal EF. The clinical impor-
ance of being able to estimate cardiac
ressures may be most apparent in the
ubgroup of HF patients who have
reserved LV systolic function. Clinical
F frequently occurs in the setting of
mpaired LV systolic function, but it is
ow well established that approxi-
ately half of HF patients (including
oth community and hospital presen-
ations) have LVEFs 45% to 50%
11). According to the European Soci-
ty of Cardiology guidelines for the
iagnosis of HF with normal EF, the
iagnosis should be made in the pres-
nce of signs and symptoms of HF,
reserved LVEF, and either invasive or
oppler echocardiographic evidence of
V diastolic dysfunction and elevated
lling pressures (12). Doppler echocar-
ng 3D Echocardiography
ultiple long-axis planes (and to cross-check
es an accurate means of measuring LV volumes,Usi
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778iography has demonstrated an in-
reased E/e= ratio in patients with HF
ith normal EF (13), and an elevated
/e= ratio has also been shown to
orrelate with invasive measures of
iastolic dysfunction (by pressure vol-
me loop analysis) in this popula-
ion (14).
In addition to the estimation of LV
lling pressure, Doppler techniques can
e used to characterize the physiology
f LV filling, which is predictive of
utcome, independent of other vari-
bles (15). Moreover, the persistence
f a restrictive filling pattern, despite
edical therapy, is predictive of out-
ome (16).
eft atrial volume. Left atrial volume
ncreases in proportion to the degree of
eft atrial pressure elevation and can be
iewed as a marker of chronic LV
iastolic pressure burden. As such, left
trial dilation is the single most impor-
ant anatomic feature to implicate a
left heart” cause of a patient’s dyspnea,
nd a diagnosis of HF should be re-
iewed when the left atrial size is
hown to be normal. Although cardiac
agnetic resonance (CMR) may be
onsidered a gold standard for the mea-
urement of left atrial volume, real-
ime 3D echocardiography will likely
rovide similar accuracy. However, left
trial volume can also be obtained rap-
dly and reliably with 2-dimensional
2D) echocardiography techniques. In-
eed, outcome studies that have dem-
nstrated the strong independent prog-
ostic value of left atrial size for
redicting adverse cardiovascular events
ave been based on 2D echocardiogra-
hy data (17). In addition, as the cur-
ent published normal ranges are also
argely derived from 2D echocardiogra-
hy, it is very appropriate to apply
chocardiography-derived cutoffs for
eft atrial volumes in the clinical set-
ing. Most importantly, because left
trial size varies with patient size, it is
ssential that volumes be adjusted for
ody surface area.
ynchrony. The current selection crite-
ia for cardiac resynchronization ther- tpy are clinical (New York Heart As-
ociation functional class III or IV on
aximal medical therapy) and electro-
ardiographic (QRS width usually
0.12 ms), but the only imaging com-
onent relates to the estimation of
VEF 35%. The evaluation of me-
hanical synchrony has been proposed
s a means of avoiding device insertion
nto likely “nonresponders” to cardiac
esynchronization therapy (at least 20%
o 30% of those implanted) and broad-
ning the indications for insertion in
hose without a wide QRS interval who
re likely to respond. Although echo-
ardiography has the highest temporal
esolution of standard cardiac imaging
odalities, the results of the Predictors
f Response to CRT (PROSPECT)
rial have been exceedingly unfavorable
18), with limited predictive ability and
oor reproducibility. The application of
chocardiography (or other imaging
odalities) for this purpose should be
onsidered as a source of ongoing in-
estigation until a simple, robust pa-
ameter of mechanical synchrony is
escribed.
itral regurgitation (MR). The extent of
R, as quantified by echocardiogra-
hy, is predictive of outcome in HF
19). Echocardiographic quantification
f MR severity is most often calculated
y the proximal isovelocity surface area
ethod. In dilated ventricles, however, it
as been shown that echocardio-
raphic measurements may be mis-
eading (20).
MR as the Principle
maging Test in HF
ichard E. Slaughter, MBBS
he Prince Charles Hospital, Brisbane,
ustralia
MR IS THE SOLE IMAGING MO-
ALITY WITH THE ABILITY TO AS-
ESS VENTRICULAR FUNCTION, CAR-
IAC MORPHOLOGY, VASCULATURE,
ERFUSION, VIABILITY, AND METAB-
LISM (21). It provides complemen-
ary and often additional information to that of standard echocardiography or
uclear imaging without the burden of
onizing radiation.
entricular function and morphology.
he increasingly sophisticated treat-
ent of patients with HF has created
he need for accurate and reproducible
easurements of cardiac chamber vol-
mes and function (22). CMR has the
bility to provide this information for
oth ventricles.
V. CMR provides optimal measure-
ents of LV volume, wall thickness,
nd mass and is more reproducible than
D echocardiography (23). CMR pro-
ides accurate measurements to guide
ritical clinical decisions based on
VEF in patient groups such as those
ith implantable defibrillators, those
eceiving cardiotoxic chemotherapy, or
hose after cardiac transplantation. The
igh spatial resolution and high signal-
o-noise ratio of steady-state free-
recession imaging permits unparalleled
ndocardial definition and delineation of
entricular morphology. This has partic-
lar application in the assessment of ab-
ormal trabecular appearances and focal
all abnormalities. Despite recent echo-
ardiographic innovations such as con-
rast echocardiography, 3D and single
eart beat 3D echocardiography, CMR
emains the gold standard for measure-
ents of LV mass, volume, and EF as
ell as for regional wall motion abnor-
alities (24,25).
CMR techniques using steady-state
ree-precession imaging show promise
n the evaluation of mechanical dys-
ynchrony (26). Improved temporal
esolution electrocardiography-gated
teady-state free-precession images al-
ow the acquisition of approximately 40
rames per heart beat and have been
roposed as an alternative technique to
chocardiography for the assessment of
yssynchrony. Real-time CMR allows
ssessment of the ventricular interde-
endence and abnormal septal motion
een in constrictive physiology and of-
en difficult to diagnose by standard
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779maging modalities (Fig. 2, Online
ideo 1). Pericardial thickness can be
easured accurately from double inver-
ion recovery images.
IGHT VENTRICLE. There is increasing
ecognition of the important role of the
ight ventricle in HF. Right ventricular
RV) dysfunction as assessed by CMR
redicts a poor prognosis after myocar-
ial infarction (27). The particular im-
ortance of RV failure in pulmonary
ypertension and in the growing pop-
lation of adults with congenital heart
isease is also being recognized. Accu-
ate RV assessment demands the use of
D techniques because of the nongeo-
etric shape of the ventricle. The RV
osition has also traditionally made re-
iable echocardiographic measure-
ents difficult. CMR is unsurpassed
n the assessment of RV volumes and
ystolic function. RV quantification
nd reproducibility can be improved
y using axial views or, preferably, the
V short-axis view in which the tri-
uspid valve is consistently well de-
ned (28).
yocardial ﬁbrosis. Myocardial late
adolinium enhancement (LGE) im-
ging provides a unique method of
issue characterization with many ap-
lications in HF. CMR is now consid-
red the gold standard investigation for
he assessment of myocardial viability
nd scarring. The presence and trans-
ural extent of LGE after myocardial
schemia give important predictive in-
ormation about the likelihood of func-
ional recovery after revascularization
30). The extent and location of scar
issue within the myocardium are also
redictive of outcomes in cardiac resyn-
hronization therapy (29).
In patients with LV dysfunction,
car burden as defined by LGE is
redictive of increased mortality or the
eed for cardiac transplantation (31).
he extent of LGE is also predictive of
V remodeling in patients with HF
rom both ischemic and nonischemic
auses (32). Previous reports have
hown that the presence of LGE can
lso distinguish ischemic from nonis- shemic dilated cardiomyopathy (33).
Interstitial fibrosis is a final common
athway for many patients with myo-
ardial damage and HF from various
tiologies. Midwall interstitial fibrosis,
s demonstrated by LGE, has been
hown to correlate with a higher rate of
ll-cause mortality and hospitalization
n patients with nonischemic dilated car-
iomyopathy (34). Contrast-enhanced
1 mapping in HF patients has been
hown to identify changes in myocar-
ial T1 times that appear to represent
nterstitial fibrosis (35).
nﬁltrative cardiomyopathies. Infiltrative
ardiomyopathies can be difficult to
iagnose with traditional imaging tech-
iques. CMR provides a more reliable
ssessment of ventricular morphology
nd hypertrophy. Characteristic pat-
erns of LGE correlate with underlying
nfiltrative process in many conditions
36). These include sarcoid, hypertro-
hic cardiomyopathy, connective tissue
iseases, myocarditis, endomyocardial
brosis, and amyloid infiltration (Fig. 3)
37). These conditions differ signifi-
antly in their natural history. Knowl-
dge of such etiologies in patients pre-
Figure 2. Real-Time Cardiac Magnetic Resonance
Pericarditis
There is marked ﬂattening of the interventricular se
interdependence. See Online Video 1.enting with HF may influence sreatment decisions, such as the need
or early implantable defibrillator inser-
ion, and also provide an opportunity
or disease-specific therapy.
By measuring T2 signal characteris-
ics, CMR has the capacity to assess
ron content in the myocardium in
halassemia, hemochromatosis, and
ther states of iron overload (38). T2
uantification has also shown correla-
ion with biopsy-proven heart trans-
lant rejection (39).
ntraventricular thrombus. CMR has
dvantages over echocardiography in
he detection of intraventricular throm-
us (40). Thrombus shows reduced sig-
al intensity compared with myocar-
ium on early contrast-enhanced
mages (Fig. 4). Left atrial appendage
hrombus can also be seen on CMR,
ut the diagnostic accuracy of CMR for
his has yet to be determined.
R. MR can be quantified with CMR
y measuring regurgitant volumes (41),
hich may overcome problems with
uantification of inhomogeneous and
ccentric MR jets by Doppler (2). An-
tomic orifice area, annular dimen-
ort-Axis View of a Patient With Constrictive
m during inspiration, indicative of ventricularSh
ptuions, and mitral tenting areas can also
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780e measured. Prolapse of valve leaflets
an be well demonstrated with indi-
idual LV long-axis oblique views
Figure 3. LGE in Inﬁltrative Myopathies
A series of 4-chamber images from different patien
enhancement (LGE) in inﬁltrative myopathies. (A) S
(B) Burnt-out hypertrophic cardiomyopathy: focal a
erythematosus/overlap syndrome: subendocardial,
ventricles. (D) Midwall and subepicardial LGE in the
endocardial LGE with apical thrombus. (F) Amyloid
ing the atria.
Figure 4. Detection of Intraventricular ThrombuAvascular thrombus shows reduced signal intensity onransecting each scallop of the mitral
alve. LGE imaging may demonstrate
apillary muscle infarction and fibrosis
owing the varied appearance of late gadolinium
idosis: patchy LGE in a noncoronary distribution.
of LGE due to autoinfarction. (C) Systemic lupus
picardial, and full-thickness areas of LGE in both
eral left ventricle. (E) Endomyocardial ﬁbrosis: sub-
kened myocardium with diffuse LGE also affect-
ing Cardiac Magnetic Resonancep
early contrast-enhanced images.n the inferior LV wall as a cause of
R (42).
iastolic function. CMR analysis of
entricular filling velocity, 3D myocar-
ial strain analysis, and real-time CMR
issue tagging are promising methods
o assess regional diastolic function
43). CMR measurements of mitral
-wave and E-wave velocity and decel-
ration times and systolic and diastolic
ave velocities in the pulmonary flow
races have been shown to be reliable
nd easy to obtain, with good correla-
ion with echocardiographic measure-
ents (44).
onclusions
he technology of both modalities is
apidly evolving, and although CMR is
ecoming more widely available, the
vailability of miniaturized systems has
ade echocardiography ubiquitous. As
s always the case, both viewpoints in
his iForum are correct. We should not
ose sight of the fact that the main
urden of HF is in the community.
he primary goal of the initial test is,
herefore, to categorize patients accord-
ng to whether they have HF with
mpaired or preserved function; this
nformation determines therapy and is
robably the reason that imaging has
een shown to have an effect on out-
ome (7) and hemodynamics. Echocar-
iography is unmatched in its ability to
ssess cardiac physiology in the clinical
etting. It is the only widely available
echnique that allows accurate nonin-
asive estimation of left atrial and pul-
onary arterial pressures. Both tests are
ble to evaluate complications of HF
uch as intracardiac thrombus, LV an-
urysm, and valve dysfunction. Echo-
ardiography remains the cardiac imag-
ng test of choice for the initial clinical
ssessment of patients with HF, not
east because of the numbers of patients
ith HF and its feasibility, availability,
nd lower cost. CMR is unsuitable forts sh
arco
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: thics Usatients with dysrhythmias that affect
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781lectrocardiographic gating, claustro-
hobia, implantable devices, or severe
enal impairment.
CMR provides a comprehensive
valuation of patients presenting with
F and should be an integral part of
valuation in many, but perhaps not all,
atients. CMR can establish an etiol-
gy and provide information that alters
anagement in a significant proportion
f patients, over and above standard
chocardiography (28). Accurate as-
essment of LV function is critical to
ecisions about device implantation. t
raphy: a multicenter comparison of methods.
J Am Coll Cardiol 2006;47:121–8.
1
1
1
1
1
1
1issue characterization is important for
ssessment of myocardial viability (re-
ional subendocardial LGE) and infil-
rative conditions that are often difficult
o diagnose with other techniques
nonischemic patterns of LGE). In
he future, fusion imaging approaches
ay maximize the value of CMR to
hose components (e.g., tissue charac-
erization) that echocardiography can-
ot readily provide. In patients unable
o undergo CMR, developments in
ontrast, 3D, and deformation imaging
echniques with echocardiography may m
604–12.
1
1
1
2
2
2
2
2
2nable this test to contribute more in
hese situations.
cknowledgments
he authors acknowledge Dr. Christian
amilton-Craig and Wendy Strugnell
rom the Prince Charles Hospital, Bris-
ane, Australia, for their contributions to
he report.
ddress for correspondence:Dr. Thomas H.
arwick, Cleveland Clinic Foundation,
ardiovascular Medicine, 9500 Euclid Av-
nue, Cleveland, Ohio 44195. E-mail:
arwict@ccf.org.E F E R E N C E S
1. Hunt SA, Abraham WT, Chin MH, et al.
2009 Focused update incorporated into the
ACC/AHA 2005 Guidelines for the Diag-
nosis and Management of Heart Failure in
Adults A Report of the American College of
Cardiology Foundation/American Heart Asso-
ciation Task Force on Practice Guidelines De-
veloped in Collaboration With the Interna-
tional Society for Heart and Lung
Transplantation. J Am Coll Cardiol 2009;53:
e1–90.
2. Nagueh SF, Middleton KJ, Kopelen HA,
Zoghbi WA, Quinones MA. Doppler tissue
imaging: a noninvasive technique for evalua-
tion of left ventricular relaxation and estima-
tion of filling pressures. J Am Coll Cardiol
1997;30:1527–33.
3. Mottram PM, Marwick TH. Assessment of
diastolic function: what the general cardiolo-
gist needs to know. Heart 2005;91:681–95.
4. Yu CM, Sanderson JE, Marwick TH, Oh JK.
Tissue Doppler imaging a new prognosticator
for cardiovascular diseases. J Am Coll Cardiol
2007;49:1903–14.
5. Yock PG, Popp RL. Noninvasive estimation
of right ventricular systolic pressure by Dopp-
ler ultrasound in patients with tricuspid re-
gurgitation. Circulation 1984;70:657–62.
6. Tribouilloy C, Rusinaru D, Mahjoub H,
Goissen T, Levy F, Peltier M. Impact of
echocardiography in patients hospitalized for
heart failure: a prospective observational study.
Arch Cardiovasc Dis 2008;101:465–73.
7. Otterstad JE, Froeland G, St John Sutton M,
Holme I. Accuracy and reproducibility of
biplane two-dimensional echocardiographic
measurements of left ventricular dimensions
and function. Eur Heart J 1997;18:507–13.
8. Hoffmann R, von Bardeleben S, Kasprzak
JD, et al. Analysis of regional left ventricular
function by cineventriculography, cardiac
magnetic resonance imaging, and unen-
hanced and contrast-enhanced echocardiog-9. Mor-Avi V, Jenkins C, Kühl HP, et al.
Real-Time 3D echocardiographic quantifica-
tion of left ventricular volumes: multicenter
study for validation with magnetic resonance
imaging and investigation of sources of error.
J Am Coll Cardiol Img 2008;1:413–23.
0. Little WC, Oh JK. Echocardiographic eval-
uation of diastolic function can be used to
guide clinical care. Circulation 2009;120:
802–9.
1. Maeder MT, Kaye DM. Heart failure with
normal left ventricular ejection fraction. J Am
Coll Cardiol 2009;53:905–18.
2. Paulus WJ, Tschope C, Sanderson JE, et al.
How to diagnose diastolic heart failure: a
consensus statement on the diagnosis of heart
failure with normal left ventricular ejection
fraction by the Heart Failure and Echocardi-
ography Associations of the European Soci-
ety of Cardiology. Eur Heart J 2007;28:
2539–50.
3. Lam CS, Roger VL, Rodeheffer RJ, et al.
Cardiac structure and ventricular-vascular
function in persons with heart failure and
preserved ejection fraction from Olmsted
County, Minnesota. Circulation 2007;115:
1982–90.
4. Kasner M, Westermann D, Steendijk P, et al.
Utility of Doppler echocardiography and tis-
sue Doppler imaging in the estimation of
diastolic function in heart failure with normal
ejection fraction: a comparative Doppler-
conductance catheterization study. Circula-
tion 2007;116:637–47.
5. Meta-analysis Research Group in Echocardi-
ography (MeRGE) Heart Failure Collabora-
tors Independence of restrictive filling pattern
and LV ejection fraction with mortality in
heart failure: an individual patient meta-
analysis. Eur J Heart Fail 2008;10:786–92.
6. Pinamonti B, Zecchin M, Di Lenarda A,
Gregori D, Sinagra G, Camerini F. Persis-
tence of restrictive left ventricular filling pat-
tern in dilated cardiomyopathy: an ominous
prognostic sign. J Am Coll Cardiol 1997;29:7. Tsang TSM, Barnes ME, Gersh BJ, et al.
Prediction of risk for first age-related cardio-
vascular events in an elderly population: the
incremental value of echocardiography. J Am
Coll Cardiol 2003;42:1199–205.
8. Chung ES, Leon AR, Tavazzi L, et al.
Results of the predictors of response to CRT
(PROSPECT) trial. Circulation 2008;117:
2608–16.
9. Grigioni F, Enriquez-Sarano M, Zehr KJ,
Bailey KR, Tajik AJ. Ischemic mitral regur-
gitation: long-term outcome and prognostic
implications with quantitative Doppler as-
sessment. Circulation 2001;103:1759–64.
0. Schwammenthal E, Chen C, Benning F,
Block M, Breithardt G, Levine RA. Dynam-
ics of mitral regurgitant flow and orifice area.
Physiologic application of the proximal flow
convergence method: clinical data and exper-
imental testing. Circulation 1994;90:307–22.
1. Pohost GM. The history of cardiovascular
magnetic resonance. J Am Coll Cardiol Img
2008;1:672–8.
2. Marwick T, Schwaiger M. The Future of
cardiovascular imaging in the diagnosis and
management of heart failure, part 1. Circ
Cardiovasc Imaging 2008;1:58–69.
3. Grothues F, Smith GC, Moon JC, et al.
Comparison of interstudy reproducibility of
cardiovascular magnetic resonance with two-
dimensional echocardiography in normal
subjects and in patients with heart failure or
left ventricular hypertrophy. Am J Cardiol
2002;90:29–34.
4. Jenkins C, Moir S, Chan J, Rakhit D,
Haluska B, Marwick TH. Left ventricular
volume measurement with echocardiography:
a comparison of left ventricular opacification,
three-dimensional echocardiography, or both
with magnetic resonance imaging. Eur
Heart J 2009;30:98–106.
5. Nagel E, Lehmkuhl HB, Bocksch W, et al.
Noninvasive diagnosis of ischemia-induced
wall motion abnormalities with the use of
high-dose dobutamine stress MRI: compari-
22
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
K
c
f
e
F
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 7 , 2 0 1 0
J U L Y 2 0 1 0 : 7 7 6 – 8 2
Slaughter and Mottram
Echo vs. CMR in Heart Failure
782son with dobutamine stress echocardiogra-
phy. Circulation 1999;99:763–70.
6. Koos R, Neizel M, Schummers G, et al.
Feasibility and initial experience of assess-
ment of mechanical dyssynchrony using car-
diovascular magnetic resonance and semi-
automatic border detection. J Cardiovasc
Magn Reson 2008;10:49.
7. Larose E, Ganz P, Reynolds HG, et al.
Right ventricular dysfunction assessed by
cardiovascular magnetic resonance imaging
predicts poor prognosis late after myocar-
dial infarction. J Am Coll Cardiol 2007;49:
855–62.
8. Strugnell WE, Slaughter RE, Riley RA,
Trotter AJ, Bartlett H. Modified RV short
axis series—a new method for cardiac MRI
measurement of right ventricular volumes.
J Cardiovasc Magn Reson 2005;7:769–74.
9. Ypenburg C, Schalij MJ, Bleeker GB, et al.
Impact of viability and scar tissue on response
to cardiac resynchronization therapy in isch-
aemic heart failure patients. Eur Heart J
2007;28:33–41.
0. Kim RJ, Wu E, Rafael A, et al. The use of
contrast-enhanced magnetic resonance imag-
ing to identify reversible myocardial dysfunc-
tion. N Engl J Med 2000;343:1445–53.
1. Kwon DH, Halley CM, Carrigan TP, et al.
Extent of left ventricular scar predicts out-
comes in ischemic cardiomyopathy patients
with significantly reduced systolic function: a
delayed hyperenhancement cardiac magnetic
resonance study. J Am Coll Cardiol Img
2009;2:34–44.
2. Bello D, Shah DJ, Farah GM, et al. Gado-
linium cardiovascular magnetic resonance
predicts reversible myocardial dysfunctionand remodeling in patients with heart failure
undergoing beta-blocker therapy. Circulation
2003;108:1945–53.
3. Casolo G, Minneci S, Manta R, et al. Iden-
tification of the ischemic etiology of heart
failure by cardiovascular magnetic resonance
imaging: diagnostic accuracy of late gadolin-
ium enhancement. Am Heart J 2006;151:
101–8.
4. Assomull RG, Prasad SK, Lyne J, et al.
Cardiovascular magnetic resonance, fibrosis,
and prognosis in dilated cardiomyopathy.
J Am Coll Cardiol 2006;48:1977–85.
5. Iles L, Pfluger H, Phrommintikul A, et al.
Evaluation of diffuse myocardial fibrosis in
heart failure with cardiac magnetic resonance
contrast-enhanced T1 mapping. J Am Coll
Cardiol 2008;52:1574–80.
6. Mahrholdt H, Wagner A, Judd RM,
Sechtem U, Kim RJ. Delayed enhancement
cardiovascular magnetic resonance assess-
ment of non-ischaemic cardiomyopathies.
Eur Heart J 2005;26:1461–74.
7. Hamilton-Craig CR, Harker J, Strugnell
WE, Slaughter RE. Diagnostic features of
endomyocardial fibrosis by cardiac MRI.
Heart, Lung Circ 2008;17:S52.
8. Anderson LJ, Holden S, Davis B, et al.
Cardiovascular T2-star (T2*) magnetic reso-
nance for the early diagnosis of myocardial
iron overload. Eur Heart J 2001;22:2171–9.
9. Butler CR, Thompson R, Haykowsky M,
Toma M, Paterson I. Cardiovascular mag-
netic resonance in the diagnosis of acute heart
transplant rejection: a review. J Cardiovasc
Magn Reson 2009;11:7.
0. Mollet NR, Dymarkowski S, Volders W, et
al. Visualization of ventricular thrombi with tcontrast-enhanced magnetic resonance
imaging in patients with ischemic heart dis-
ease. Circulation 2002;106:2873–6.
1. Gelfand EV, Hughes S, Hauser TH, et al.
Severity of mitral and aortic regurgitation as
assessed by cardiovascular magnetic reso-
nance: optimizing correlation with Doppler
echocardiography. J Cardiovasc Magn Reson
2006;8:503–7.
2. D’Ancona G, Biondo D, Mamone G, et al.
Ischemic mitral valve regurgitation in pa-
tients with depressed ventricular function:
cardiac geometrical and myocardial perfu-
sion evaluation with magnetic resonance
imaging. Eur J Cardiothorac Surg 2008;34:
964–8.
3. Paelinck BP, Lamb HJ, Bax JJ, Van der Wall
EE, de Roos A. Assessment of diastolic func-
tion by cardiovascular magnetic resonance. Am
Heart J 2002;144:198–205.
4. Rathi VK, Doyle M, Yamrozik J, et al.
Routine evaluation of left ventricular diastolic
function by cardiovascular magnetic reso-
nance: a practical approach. J Cardiovasc
Magn Reson 2008;10:36.
ey Words: cardiomyopathy y
ardiac magnetic resonance y heart
ailure y late gadolinium
nhancement y ventricular function.
A P P E N D I X
or a supplementary video and its legend, please seehe online version of this article.
